Variables | Group Tv-RARP (n = 29) | Group Ep-RARP (n = 37) | P-value |
---|---|---|---|
Age (years) BMI | 67.86 ± 6.68 | 68.11 ± 7.06 | 0.886 |
24.22(22.45–27.44) | 23.53(21.45–24.72) | 0.111 | |
Prostate volume | 40.11(26.95–62.82) | 32.76(25.27–45.54) | 0.129 |
Preoperative PSA | 18.29(13.70–27.50) | 29.10(13.59–53.22) | 0.177 |
History of abdominal surgery | 3(10.34%) | 5(13.51%) | 0.294 |
Preoperative Gleason score | 0.791 | ||
≤ 6 | 15(50.00%) | 16(12.20%) | |
7 | 8(28.57%) | 12(24.39) | |
≥ 8 | 6(21.43%) | 9(63.41%) | |
Clinical stages | 0.600 | ||
T1 | 11(37.93%) | 11(29.73%) | |
T2 | 18(62.07%) | 26(70.27%) | |
History of neoadjuvant therapy | 2(6.90%) | 2(5.40%) | 1.000 |